Quality of Life clinical trials at UCSF
6 in progress, 3 open to eligible people
Quality of life refers to how well a person lives. UCSF explores reasons for tiredness in cancer patients undergoing treatment and ways to help those with congenital heart disease take charge of their health. The institution also studies recovery paths after different anesthesia methods in surgery.
Improving Congenital Heart Disease Care
open to eligible people ages 18 years and up
The theory-informed digital health intervention, called as "Empower My Congenital Health (EmpowerMyCH)" aims to activate and engage ACHD patients in building confidence toward navigating the adult healthcare system. This tool is built after incorporating the theories of behavior change, gathering inputs from target patients in all stages of its design and implementation. The key features of the tool include a digital medical passport, updated congenital information, community support, and patient stories and advice. The investigators aim to test the acceptability, feasibility, efficacy, and effectiveness of the intervention.
San Francisco, California
Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial
open to eligible people ages 18 years and up
The investigators will conduct a 13,000-patient randomized multi-center trial to determine (i) which general anesthesia technique yields superior patient recovery experiences in any of three surgical categories ((a) major inpatient surgery, (b) minor inpatient surgery, (c) outpatient surgery) and (ii) whether TIVA confers no more than a small (0.2 %) increased risk of intraoperative awareness than INVA in patients undergoing both outpatient and inpatient surgeries
San Francisco, California and other locations
Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT
open to eligible people ages 18 years and up
Cancer-related fatigue (CRF) is a significant problem for cancer patients. This prospective, basic science, observational study will evaluate for changes in CRF associated with molecular characteristics prior to, during, and at the completion of non-investigational, standard-of-care, combined chemotherapy and radiation therapy (CCRT) and to develop and assess predictive models for CRF severity.
San Francisco, California
Patient Care Outreach, Navigation, Technology and Support 2.0
Sorry, currently not accepting new patients, but might later
This is a feasibility study employing virtual patient navigation for underserved individuals who speak English, Chinese or Spanish and were diagnosed with breast cancer or cardiovascular disease to determine the extent of usability for a virtual patient navigation portal serving people in underserved communities. While not able to entirely replace in-person interactions, virtual patient navigation may be used to expand reach and availability of navigation services to a much greater segment of the population.
San Francisco, California and other locations
Digital Symptom Tracking, Patient Engagement and Quality of Life in Advanced Cancer
Sorry, in progress, not accepting new patients
The purpose of this study is to (1) describe patient and clinician engagement in web-based symptom self-monitoring, (2) identify differences in symptom management between intervention and usual care groups, and (3) identify potential outcomes of real-time symptom tracking and management. With the assistance of the study coordinator, participants randomized to the intervention will create an account with Noona. Patients will be instructed to log symptoms as often as relevant using their own personal devices. Patients will also be prompted once per week for 24 weeks to log any recent symptoms. These participants will be sent a Symptom Questionnaire (SQ) via the Noona tool that summarizes their symptoms and distress one week prior to each oncology clinic visit. Symptoms designated as clinically severe either during regular symptom logging or via the SQ will trigger a prompt to contact the clinical team for immediate follow-up.
San Francisco, California and other locations
Evaluating Biomarkers of Cognitive Dysfunction in Patients With Cancer
Sorry, not yet accepting patients
This study investigates the effects of brain radiotherapy on cognitive function by evaluating plasma biomarkers and apolipoprotein E (APOE) genotype in patients with primary or metastatic brain tumors. Standard brain radiotherapy is known to impact cognitive outcomes, yet the underlying biological mechanisms remain unclear.
San Francisco, California
Our lead scientists for Quality of Life research studies include Jean Nakamura, MD Jeremy Juang, MD Scarlett L Gomez, PhD Matthieu Legrand, MD Sue Yom, MD Anushree Agarwal, MBBS, MAS.
Last updated: